Will Andrews
Chief Medical Officer @Catalyst Pharmaceuticals, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Chief Medical Officer @Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases.
EDUCATION
Yale School of Medicine
Doctor of Medicine - MD
Harvard University
Bachelor of Arts/Science, Biology
SKILLS
ABOUT WILL ANDREWS
I am a biopharmaceutical executive and leader driven by my passion to help patients around the world with innovative therapies, to further organizational success, and to optimize business practices and growth. I focus on maximizing the clinical value of product portfolios for patients, healthcare communities, and shareholders. I accomplish this by building high performing teams, assessing value-adding business opportunities, and leveraging my deep expertise in global biopharmaceuticals, clinical development, medical affairs, and go-to-market strategy. I also have extensive experience in rare diseases and have been instrumental in launching seven therapeutic products. CEO’s place their trust in me to lead global, enterprise-wide medical and pharmaceutical initiatives as I consistently focus on the health and wellbeing of patients. Below are highlights of my career accomplishments and specialties:• Reported to the CEO as a Section 16 Officer in my previous four companies, with significant investor, analyst, and Board interactions, external corporate representation, and non-raise/raise roadshows.• Built companies and functions from scratch, led change management and merger and acquisition integration initiatives, and directed multi-national teams and operating budgets, which consistently propelled organizational performance. • Designed and oversaw Phase clinical trials in a variety of therapeutic areas, with a focus on rare diseases. Have designed and driven Phase IV studies, Registry trials, real-world data/real-world evidence projects, Health Economics and Outcomes Research, and REMS programs.• Led clinical efforts and representation with regulatory authorities in the US, EU, Canada, South America and Asia, which led to new drug submissions and product approvals.• Launched seven therapeutics products resulting in corporate revenue growth, expansion of brand business, and increased corporate public visibility.Specialties: Global Experience | Corporate Strategy | Internal Medicine Physician | Clinical Development | Medical Affairs | Rare Diseases | Clinical/Regulatory Strategy | Regulatory Agency Interactions and Submissions | Product Launches | External Corporate Representation | Influential Speaker | Governance | Compliance | Corporate Transactions | Business Transformation | Go-To-Market Strategies | Business Development | Multi-national and Cross-functional Team Leadership
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.